Spoke at #BIO2025 on what’s next in obesity care.
GLP-1s changed my life - but what gave me hope today was sharing the stage with leaders like @bevtchangmd, Punit Dhillon, Steffen Sebastian-Bolz & @JonahComstock.
Science matters. So does who we build it for.
#GLP1#obesitycare
Obesity is a disease, but that is still a new concept to many people.
Through Thrive Together, OAC is helping the next generation challenge outdated ideas, reduce blame and understand obesity with more compassion, science-based education and support. Learn more here: https://t.co/OhhXwbOskL
#ThriveTogether #ObesityCare #WeightBias
I think today marks the end of my time with @JetBlue. Mosaic for many years. Issues have been building awhile now. But today’s flight to Las Vegas is truly the final straw. I’m sad.
Tired of plain water? You’re not alone.
Hydration doesn’t have to be boring—or packed with sugar. From fruit-infused water to iced teas and refreshing recipes like watermelon slushies, there are so many fun ways to stay cool and support your health this summer. Get inspired: https://t.co/55zrsnJt33
#StayHydrated #OAC #YourWeightMatters #Blog
Access to obesity meds isn’t a luxury. It’s care.
I joined Downsized Dish at #YWM2025 to talk GLP-1s, Capitol Hill, and what I wish new patients knew.
Proud to speak from lived experience and fight for access for all.
https://t.co/mrO5kZfeW9 via @YouTube
On Capitol Hill today with @ObesityAction, I stood alongside clinicians -some of whom are also patients - to advocate for better obesity care.
Because when science and lived experience speak together, people listen.
#TROA#YWM2025#GLP1#ObesityCare#OACAction
Headed to DC to share what GLP-1s made possible and to fight for the people who still can’t access them.
Obesity care should be science-based, not stigma-based.
Let’s get #TROA passed. #GLP1#YWM2025@ObesityAction
U.S. tirzepatide prescriptions are now adding 650,000 new patients every month.
– 500K for obesity (Zepbound)
– 150K for diabetes (Mounjaro)
Novo’s Wegovy + Ozempic - 220K combined.
This isn’t a lead. It’s a rout.
GLP-1 is a war. And Lilly came loaded.
The only thing more American than fireworks and hot dogs?
A life-changing medication most people can’t afford.
GLP-1s helped me reclaim my health.
Access shouldn’t be a luxury.
Happy 4th. 🇺🇸
#4thofJuly#obesitymedicine#glp1
I guest hosted @ThePlusSideZ and interviewed @DavidAKesslerMD, former FDA Commissioner and author of Diet, Drugs & Dopamine.
We talked GLP-1s, access, and the future of obesity care.
The last hour is incredibly powerful.
#glp1#obesitymedicine
https://t.co/HvvpD4Ihar
My latest video on how patients should be playing more of a role in y’all’s GLP-1 Gold Rush. Our lived experience matters.
https://t.co/HVEKMKOheu
#glp1#aom#obesitymedicine
“You have one industry making billions of dollars..,selling food that’s making us sick. You have another industry…. making equal profits to reverse what the former industry does. Anyone coming down from Mars would say ‘hey, that picture is screwed up”
@DavidAKesslerMD
In Diet, Drugs & Dopamine, @DavidAKesslerMD shows how ultra-processed food hijacks the brain—triggering dopamine like addictive drugs.
GLP-1s can break that loop.
But without policy change? Big Food still wins.
We dig in on @ThePlusSideZ—episode soon.
#GLP1#ObesityCare#bigfood
I got the humbling chance to guest host @ThePlusSideZ and interview @DavidAKesslerMD.
He helped take on Big Tobacco. Now he’s naming obesity for what it is: a disease.
We talked stigma, shame, and access.
As someone who’s lived this - this one meant a lot.
Episode drops soon.
@DrPlantel Why does the conversation always have to be one or the other? We didn’t say to people with lung cancer that they couldn’t get treatment until we shut down big tobacco. Why is obesity different?